Angioectasias Diagnosis

Diagnosis combines the bleeding history, CBC and iron studies, medication review, and direct visualization. EGD, colonoscopy, capsule endoscopy, or enteroscopy may identify the fragile vessels, while imaging is used when bleeding is active or difficult to localize.

Tests may include CBC, ferritin, iron saturation, stool blood testing, EGD, colonoscopy, capsule endoscopy, device-assisted enteroscopy, CT angiography, radionuclide bleeding scan, and catheter angiography. The choice depends on bleeding speed and prior results.

The gastroenterologist reviews stool color, anemia trends, transfusions, medicines, kidney and heart disease, and previous procedures. Testing then targets the most likely source, often beginning with EGD or colonoscopy and progressing to small-bowel evaluation if needed.

Yes. EGD can detect lesions in the upper GI tract, colonoscopy can detect colonic lesions, and enteroscopy can reach portions of the small bowel. Angioectasias may be missed if they are small, hidden by preparation quality, or not actively bleeding.

Colonoscopy is appropriate when lower GI bleeding, iron-deficiency anemia, or a colonic source is suspected. It can identify angioectasias, exclude tumors and inflammation, and often treat lesions during the same procedure.

A gastroenterologist may apply argon plasma coagulation or another thermal therapy to close the fragile vessel. Treatment technique depends on lesion size, location, active bleeding, surrounding tissue, and procedural access.

Argon plasma coagulation is commonly used. Other options may include contact thermal coagulation, clips in selected lesions, or combination therapy. The method is individualized to reduce bleeding while limiting injury to the bowel wall.

Management may include oral or intravenous iron, treatment of the bleeding lesion, monitoring hemoglobin and ferritin, and transfusion for severe or symptomatic anemia. Ongoing losses require reassessment for recurrent or additional lesions.

Medication may be considered when bleeding recurs despite endoscopic therapy, lesions are numerous or inaccessible, or repeated procedures are high risk. Somatostatin-based therapy or other selected agents require specialist review of benefits and adverse effects.

Multiple lesions, small-bowel involvement, chronic kidney disease, aortic stenosis, heart failure, LVAD use, cirrhosis, clotting disorders, and necessary anticoagulant or antiplatelet therapy can increase recurrence risk.

Capsule endoscopy is commonly used after adequate upper and lower endoscopy do not find the source. Positive findings can guide device-assisted enteroscopy for confirmation and treatment. CT imaging may be added when another small-bowel disorder is suspected.

Follow-up usually includes symptom review, CBC and iron studies, assessment of iron replacement, and monitoring for black stool or visible blood. The timing of repeat endoscopy depends on recurrence rather than a single universal schedule.

Yes. Treated vessels can recur and new lesions can form elsewhere. Recurrent anemia or bleeding should prompt repeat evaluation rather than assuming the original lesion is the only source.

They consider whether bleeding is active, anemia severity, lesion number and location, prior response, age, medical conditions, anticoagulant needs, and procedural risk. Incidental nonbleeding lesions may not require therapy.

See a gastroenterologist for unexplained iron-deficiency anemia, recurrent low hemoglobin, black stool, rectal bleeding, or persistent symptoms after negative initial tests. Heavy bleeding, fainting, chest pain, or shortness of breath at rest requires emergency care.